A guide to the treatment of adults with ADHD

Journal of Clinical Psychiatry

Volumn 65, Issue SUPPL. 3, 2004, Pages 27-37

  Weiss, Margaret D ^a,b   Weiss, Jacqueline R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGING; ATTENTION DEFICIT DISORDER; COMORBIDITY; DIFFERENTIAL DIAGNOSIS; HUMAN; ONSET AGE; PATIENT EDUCATION; PRACTICE GUIDELINE; REVIEW; SOCIAL SUPPORT;

ADULT; AGE OF ONSET; AGING; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; HUMANS; PATIENT EDUCATION; PRACTICE GUIDELINES; SOCIAL SUPPORT;

EID: 2142716773     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
2. Barkley RA, Fischer M, Fletcher K, et al. Persistence of attention deficit hyperactivity disorder into adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol 2002;111:279-289
3. Adler LA, Spencer T, Faraone SV, et al. Validity of patient administered ADHD RS to rate adult ADHD symptoms. Presented at the 43rd annual meeting of the New Clinical Drug Evaluation Unit, May 27-30, 2003; Boca Raton, Fla
4. U.S. Census Bureau. Census 2000 data. Available at: http://factfinder. census.gov. Accessed Sept 23, 2003
5. Dulcan M. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolecent Psychiatry. J Am Acad Child Adolesc Psychiatry 1997;40(suppl 10):85S-121S
6. Murphy K, Barkley RA. Prevalence of DSM-IV symptoms of ADHD in adult licensed drivers: implications for clinical diagnosis. J Atten Disord 1996;1:147-161
7. Wender PH, Wolf LE, Wasserstein J. Adults with ADHD: an overview. Ann N Y Acad Sci 2001;931:1-16
8. Heiligenstein E, Keeling RP. Presentation of unrecognized attention deficit hyperactivity disorder in college students. J Am Coll Health 1995;43:226-228
9. Heiligenstein E, Conyers LM, Berns AR, et al. Preliminary normative data on DSM-IV attention deficit hyperactivity disorder in college students. J Am Coll Health 1998;46:185-188
10. Heiligenstein E, Conyers LM, Berns AR, et al. Psychological and academic functioning in college students with attention deficit hyperactivity disorder. J Am Coll Health 1999;47:181-185
11. Faraone SV, Biederman J, Spencer T, et al. Attention-deficit/ hyperactivity disorder in adults: an overview. Biol Psychiatry 2000;48:9-20
12. Conners D, Epstein J, Johnson D. Conners Adult ADHD Diagnostic Interview for DSM-IV. North Tonawanda, NY: Multi-Health Systems; 2001
13. Brown TE. Brown Attention-Deficit Disorder Scales. San Antonio, Tex: The Psychological Corporation; 1996
14. Conners CK, Erhart D, Sparrow E. Conners' Adult ADHD Rating Scales, Technical Manual. New York, NY: Multi-Health Systems; 1999
15. Barkley RA, Murphy KR. Attention-Deficit Hyperactivity Disorder: A Clinical Workbook, Second Edition. New York, NY: Guilford Press; 1998
16. Gadow K, Sprafkin J, Weiss MD. Adult Inventories. New York, NY: Checkmate Plus; 1999
17. McDermott SP. Cognitive therapy for adults with attention-deficit/ hyperactivity disorder. In: Brown TE, ed. Attention-Deficit Disorders and Comorbidities in Children, Adolescents, and Adults. 1st ed. Washington, DC: American Psychiatric Press; 2000:569-606
18. Wilens T, Biederman J, Spencer TJ. Cognitive therapy in the treatment of adults with ADHD: a systematic chart review of 26 cases. J Cognit Psychother 1999;13:215-226
19. Wilens TE, Spencer TJ, Biederman J. A review of the pharmacotherapy of adults with Attention-Deficit/Hyperactivity Disorder. J Atten Disord 2002; 5:189-202
20. Weiss M, Trokenberg Hechtman L, Weiss G. ADHD in Adulthood. Baltimore, Md: Johns Hopkins University Press; 1999
21. Weiss M, Murray C. Assessment and management of attention-deficit hyperactivity disorder in adults. CMAJ 2003;168:715-722. Available at: http://www.cmaj.ca/cgi/reprint/168/6/715. Accessed Oct 16, 2003
22. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993;150:885-890
23. Brown T. Attention-Deficit Disorders and Comorbidities in Children, Adolescents, and Adults. Washington, DC: American Psychiatric Press; 2000
24. Pliszka SR, Carlson CL, Swanson JM. ADHD with Comorbid Disorders: Clinical Assessment and Management. New York, NY: Guilford Press; 1999
25. Pliszka SR. Patterns of psychiatric comorbidity with attention-deficit/ hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 2000;9: 525-540
26. Pliszka SR, Greenhill LL, Crismon ML, et al. The Texas Children's Medication Algorithm Project: report of the Texas Consensus Conference Panel on medication treatment of childhood attention-deficit/hyperactivity disorder, pt 2: tactics. J Am Acad Child Adolesc Psychiatry 2000;39:920-927
27. Medsafe. New Zealand Information for Health Professionals Data Sheet: Risperdal. April 2002. Available at: http://www.medsafe.govt.nz/Profs/ Datasheet/r/risperdaltabsol.htm. Accessed July 10, 2003
28. Leckman JF, Zhang H, Vitale A, et al. Course of tic severity in Tourette syndrome: the first two decades. Pediatrics 1998;102:14-19
29. Spencer T, Coffey B, and Biederman J. Chronic tics in adults with ADHD. In: Scientific Proceedings of the Annual Meeting XVIII American Academy of Child and Adolescent Psychiatry; Oct 22-27, 2002; San Francisco, Calif. Pages 76-77
30. Castellanos FX, Giedd JN, Elia J, et al. Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose. J Am Acad Child Adolesc Psychiatry 1997;36:589-596
31. Attwood T. Asperger's Syndrome: A Guide for Parents and Professionals. London, England: Jessica Kingsley; 1998
32. Weissman MM. Social Adjustment Scale-Self-Report. New York, NY: Multi-Health Systems; 1999
33. Keller MB, Lavori PW, Friedman B, et al. The Longitudinal Interval Follow-Up Evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry 1987;44:540-548
34. Endicott J, Nee J, Harrison W, et al. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993;29:321-326
35. Hallowell EM, Ratey J. Driven to Distraction: Recognizing and Coping with Attention-Deficit Disorder from Childhood through Adulthood. New York, NY: Pantheon Books; 1994
36. Barkley RA. ADHD in Adults [video]. New York, NY: Guilford Press; 1994
37. McCann BS, Roy-Byrne P. Attention-deficit/hyperactivity disorder and learning disabilities in adults. Semin Clin Neuropsychiatry 2000;5: 191-197
38. Barkley RA, Murphy KR, Kwasnik D. Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics 1996;98(6 pt1):1089-1095
39. Biederman J, Wilens TE, Mick E, et al. Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biol Psychiatry 1998;44:269-273
40. Spencer T, Biederman J, Wilens T, et al. Pharmacotherapy of attentiondeficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 1996;35:409-432
41. Wilens TE, Biederman J, Spencer TJ, et al. Pharmacotherapy of adult attention deficit/hyperactivity disorder: a review. J Clin Psychopharmacol 1995;15:270-278
42. Wilens TE, Spencer TJ, Biederman J. Pharmacotherapy of adult ADHD. In: Barkley RA, ed. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. New York, NY: Guilford Press; 2001:596-606
43. Spencer T, Wilens T, Biederman J, et al. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhoodonset attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1995;52:434-443
44. Spencer T, Biederman J, Wilens T, et al. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2001;58:775-782
45. Greenhill LL, Pliszka S, Dulcan MK, et al. Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 2001;40:1352-1355
46. Wilens TE, Spencer TJ, Biederman J, et al. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry 2001;158:282-288
47. Wilens TE, Biederman J, Prince J, et al. Six-week, double-blind, placebocontrolled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry 1996;153:1147-1153
48. Spencer T, Biederman J, Wilens T, et al. Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1998;155:693-695
49. Michelson D, Adler L, Spencer T, et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry 2003;53:112-120
50. Michelson D, Faries D, Wernecke J, et al, the Atomoxetine ADHD Study Group. Atomoxetine in the treatment of children and adolescents with attention-deficit hyperactivity disorder: a randomized, placebo-controlled, dose response study. Pediatrics 2001;108:E83
51. Biederman J, Faraone SV, Mick E, et al. High risk for attention deficit hyperactivity disorder among children of parents with childhood onset of the disorder: a pilot study. Am J Psychiatry 1995;152:431-435
52. Ratey J, Greenberg MS, Bemporad JR, et al. Unrecognized attentiondeficit hyperactivity disorder in adults presenting for outpatient psychotherapy. J Child Adolesc Psychopharmacol 1992;2:267-275